HE Dr. Amin Hussein Al Amiri, Assistant Under-Secretary for Public Health Policy and Licensing Sector at the Ministry of Health and Prevention, stated that the Ministry is cooperating with pharmaceutical companies to support patent programs and registration of patents at the Ministry of Economy.
HE Dr. Al Amiri pointed out that the Ministry has organized several workshops and meetings last week, which included representatives from the Ministry of Health and Prevention, the Ministry of Economy, local factories, economic bodies, and international drug manufacturing companies, in addition to an expert from the World Intellectual Property Organization (WIPO). The meetings included discussions on the topic of drug patents and ways to support the efforts of pharmaceutical companies in registering their patents at the Ministry of Economy.
HE Dr. Amin Hussein Al Amiri stated that the UAE provides all types of support and facilities to help with registering drug patents, and it is considered at the forefront in terms of the speed of completing drug patent transactions. He appealed to companies to work on patenting their innovative products in the UAE in accordance with the Federal Law No. (31) of 2006, as it preserves their rights to their products. He pointed out that the process of supporting companies and helping them to register patents for their products falls within the framework of the Ministry's strategy, which aims to help companies maintain their achievements and innovations in the field of pharmaceutical drugs.
HE Dr. Al Amiri clarified that registering patents for pharmaceutical products is considered an indication of the development of the healthcare sector in a country, due to the fact that patents guarantee the rights for all concerned parties and promotes a spirit of fair competition between companies.
HE Dr. Amin Hussein Al Amiri praised local and international companies based in the UAE that work in the field of scientific research. He also praised the role of these companies in inventing, developing and manufacturing medicines. He called on these companies to register patents for drugs that they have developed through their research efforts.